Key proteins and genetic materials

We develop and produce key proteins and genetic materials for biopharma and food industry. Industry collaboration is an important pillar of our strategy.

Promising Q3 2022

September 6th, 2022|

With the outlicensing of our HSV-2 vaccine program to Eurocine Vaccines (Sweden) Redbiotec has achieved one of its biggest goals [...]

BIO Digital 2020

May 29th, 2020|

Date: June 8-12, 2020 At a time when collaboration is more vital than ever, the Redbiotec team looks forward [...]

Go to Top